StockData

Lycia Therapeutics, Inc. (LYCA) income statement

LYCANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$31.35+0.43 (+1.39%)

Close on Nov 18, 2026Market cap –P/E –Yield –

Lycia Therapeutics, Inc. income statement

Ratios

Latest available

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY
–

Financial strength

Current ratio
–
Debt to equity
–
Debt to assets
–
Cash to current liabilities
–

Valuation

P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–

See a number that looks wrong?